Expression of the human concentrative nucleotide transporter 1 (hCNT1) gene correlates with clinical response in patients affected by Waldenström's Macroglobulinemia (WM) and small lymphocytic lymphoma (SLL) undergoing a combination treatment with 2-chloro-2′-deoxyadenosine (2-CdA) and Rituximab
To access this article, please choose from the options below
PII: S0145-2126(09)00349-X
doi:10.1016/j.leukres.2009.07.002
© 2009 Elsevier Ltd. All rights reserved.
